RMC-6291, a next-generation tri-complex KRAS(G12C)(ON) inhibitor, outperforms KRAS(G12C)(OFF) inhibitors in preclinical models of KRAS(G12C) cancersRobert J. Nichols, Y. C. Yang,Jim Cregg,Chris J. Schulze,Zhican Wang, Richa Dua,Jingjing Jiang,Lindsay S. Garrenton,Nicole Nasholm,Alun Bermingham,John E. Knox,Kyle Seamon,Michael Longhi,Kang-Jye Chou,Shaoling Li,David P. Wildes,Mallika Singh,Elena S. Koltun,Adrian L. Gill,Jacqueline A. M. SmithCANCER RESEARCH(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要